HAMBURG, Germany and OXFORD, England, February 9 /PRNewswire-FirstCall/ -- Evotec OAI today announced that Dr Dirk Ehlers, CFO of Evotec OAI, will present at the UBS Global Healthcare Services Conference at 01.00 p.m. ET on Tuesday, 15 February 2005, at The Plaza in New York City.
The audio portion of the presentation will be a webcast via the UBS website at http://www.ibb.ubs.com/. The accompanying slides are available on request. Please e-mail to: firstname.lastname@example.org.
About Evotec OAI AG
Evotec OAI is a leader in the discovery and development of the next generation of novel small molecule based drugs through both contract research partnerships and discovery programmes for out-licensing. The Company provides innovative solutions from target to clinic through an unmatched range of integrated capabilities ranging from assay development and screening through to medicinal chemistry and drug manufacturing. As a result, Evotec OAI has established itself as the partner of choice for pharmaceutical and biotechnology companies worldwide. With over 600 people located in Hamburg, Germany and near Oxford, UK, Evotec OAI is committed to generate value to its partners, shareholders and employees through a sustainable strategy that balances short-term and long-term business opportunities.
Evotec OAI AG
Director Investor Relations &
Evotec OAI AG
CONTACT: Contact: Evotec OAI AG, Anne Hennecke, Director InvestorRelations & Corporate Communications, Phone:+49-(0)40-5-60-81-286 email@example.com